[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma]

Endocrinol Nutr. 2011 Apr;58(4):204-6. doi: 10.1016/j.endonu.2010.11.005. Epub 2011 Mar 9.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • 3-Iodobenzylguanidine
  • Acute Coronary Syndrome / etiology*
  • Adrenal Gland Neoplasms / complications*
  • Adrenal Gland Neoplasms / diagnostic imaging
  • Adrenal Gland Neoplasms / drug therapy
  • Adrenal Gland Neoplasms / metabolism
  • Adrenal Gland Neoplasms / surgery
  • Adrenal Gland Neoplasms / urine
  • Adrenalectomy
  • Catecholamines / metabolism*
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Dyslipidemias / complications
  • Female
  • Humans
  • Hypertension / etiology
  • Metanephrine / urine
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Phenoxybenzamine / therapeutic use
  • Pheochromocytoma / complications*
  • Pheochromocytoma / diagnostic imaging
  • Pheochromocytoma / drug therapy
  • Pheochromocytoma / metabolism
  • Pheochromocytoma / surgery
  • Pheochromocytoma / urine
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Vanilmandelic Acid / urine
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Catecholamines
  • Radiopharmaceuticals
  • Phenoxybenzamine
  • 3-Iodobenzylguanidine
  • Metanephrine
  • Vanilmandelic Acid